GlucoLight Corporation Raises Third Tranche Of "C" Round Financing

Published: Mar 18, 2008

BETHLEHEM, Pa.--(BUSINESS WIRE)--GlucoLight Corporation, a development-stage company focused on non-invasive, continuous blood glucose monitoring, today announced the closing of the third tranche of its ā€œCā€ round financing. The amount of the third tranche was not disclosed. In addition to the second tranche of financing announced in February, GlucoLight is nearing the close of its ā€œCā€ round.

Back to news